Jigishu Ahmed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jigishu Ahmed has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Abdur Rouf Siddique
Clinical Hematology and Cancer Biology Laboratory, Laboratory Sciences and Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka 1212, Bangladesh
1 shared publication - Anamul Hasan
Infectious Diseases Division, International Centre for Diarrheal Disease Research, Bangladesh (ICDDR,B), Dhaka, Bangladesh
1 shared publication Asaduzzaman Asad
ICDDR,B
1 shared publicationAvizit Das
Jashore University of Science and Technology
1 shared publication- Bikash Chandra Chanda
Clinical Hematology and Cancer Biology Laboratory, Laboratory Sciences and Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka 1212, Bangladesh
1 shared publication - Dinesh Mondal
International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh
1 shared publication
Latest Publications
- Open Access
- 22 September 2026
- Published by SAGE Publications in Bioinformatics and Biology Insights
- Vol. 20
Integrative Bioinformatics Analysis Reveals Convergent Immune Dysregulation in Th17 Cell Differentiation and JAK-STAT Signaling Pathways in Cytomegalovirus Infection and Guillain-Barré Syndrome
Guillain-Barré Syndrome (GBS) is a post-infectious autoimmune neuropathy and the leading cause of acute flaccid paralysis worldwide, frequently triggered by preceding infections including Campylobacter jejuni and cytomegalovirus (CMV). Unlike C. jejuni -associated GBS, the immunopathogenic mechanisms underlying CMV-associated GBS remain poorly defined. Using an integrative immunoinformatic approach, we separately analyzed disease-associated genes from DisGeNET and publicly available PBMC transcriptomic datasets from CMV-infected and GBS patients from the Gene Expression Omnibus. Differentially expressed genes (DEGs), protein–protein interaction networks, and pathway enrichment analyses were performed to identify shared immune signatures. We identified 245 common DEGs, with hub genes including TNF, IL-1β, IL-6, IL-10, TLR4, and ICAM-1. Pathway analyses revealed significant enrichment of Th17 cell differentiation, JAK–STAT signaling, cytokine–cytokine receptor interaction, and chemokine signaling in both diseases. Despite convergence on shared pathways, key immune genes were predominantly downregulated in CMV infection but upregulated in GBS, suggesting context-dependent pathway regulation across the transition from acute viral infection to post-infectious autoimmunity. These findings provide a mechanistic framework linking CMV-induced immune perturbation and autoimmune neuropathy, and highlight Th17 differentiation and JAK-STAT signaling as central dysregulated pathways in CMV-associated GBS warranting experimental validation.
- 22 September 2026
- Published by SAGE Publications in Bioinformatics and Biology Insights
- Vol. 20
Open AccessIntegrative Bioinformatics Analysis Reveals Convergent Immune Dysregulation in Th17 Cell Differentiation and JAK-STAT Signaling Pathways in Cytomegalovirus Infection and Guillain-Barré Syndrome
Guillain-Barré Syndrome (GBS) is a post-infectious autoimmune neuropathy and the leading cause of acute flaccid paralysis worldwide, frequently triggered by preceding infections including Campylobacter jejuni and cytomegalovirus (CMV). Unlike C. jejuni -associated GBS, the immunopathogenic mechanisms underlying CMV-associated GBS remain poorly defined. Using an integrative immunoinformatic approach, we separately analyzed disease-associated genes from DisGeNET and publicly available PBMC transcriptomic datasets from CMV-infected and GBS patients from the Gene Expression Omnibus. Differentially expressed genes (DEGs), protein–protein interaction networks, and pathway enrichment analyses were performed to identify shared immune signatures. We identified 245 common DEGs, with hub genes including TNF, IL-1β, IL-6, IL-10, TLR4, and ICAM-1. Pathway analyses revealed significant enrichment of Th17 cell differentiation, JAK–STAT signaling, cytokine–cytokine receptor interaction, and chemokine signaling in both diseases. Despite convergence on shared pathways, key immune genes were predominantly downregulated in CMV infection but upregulated in GBS, suggesting context-dependent pathway regulation across the transition from acute viral infection to post-infectious autoimmunity. These findings provide a mechanistic framework linking CMV-induced immune perturbation and autoimmune neuropathy, and highlight Th17 differentiation and JAK-STAT signaling as central dysregulated pathways in CMV-associated GBS warranting experimental validation.
- Open Access
- 10 May 2023
- Published by MDPI AG in Thalassemia Reports
- Vol. 13 (2) , 131-143
Spectrum of Thalassemia and Hemoglobinopathy Using Capillary Zone Electrophoresis: A Facility-Based Single Centred Study at icddr,b in Bangladesh
Background: Although the global thalassemia zone covers Bangladesh, there are very limited studies conducted in this region. Therefore, the focus of our study is to understand the prevalence and burden of thalassemia and hemoglobinopathy in Bangladesh. Methods: The analysis was based on a retrospective evaluation of laboratory diagnoses between 2007 January and 2021 October. A total of 8503 specimens were sampled and analyzed which were either referred by corresponding physicians or self-referred. This was neither any epidemiological nationwide survey nor was the study population chosen randomly. Hematological data were obtained through capillary zone electrophoresis and corresponding complete blood count. Results: 1971 samples (~23.18% of the total) were found with at least one inherited hemoglobin disorder. The most common hemoglobin disorder observed was the hemoglobin E (Hb E) trait (10.67%), followed by the β-thalassemia trait (8.4%), homozygotic Hb E (1.59%), and Hb E/β-thalassemia (1.58%). Other variants found in this study with minimal percentages were Hb N-Seattle, Hb S, Hb D-Punjab, Hb Lepore, Hb C, Hb Hope, Hb H, and hereditary persistence of fetal hemoglobin. Discussion: The pattern of thalassemia and hemoglobinopathy in our study is diverse and heterogeneous. A broad and detailed spectrum of such inherited hemoglobin disorders will ultimately be helpful in implementing nationwide thalassemia management and strategy policy in Bangladesh.
- 10 May 2023
- Published by MDPI AG in Thalassemia Reports
- Vol. 13 (2) , 131-143
Open AccessSpectrum of Thalassemia and Hemoglobinopathy Using Capillary Zone Electrophoresis: A Facility-Based Single Centred Study at icddr,b in Bangladesh
Background: Although the global thalassemia zone covers Bangladesh, there are very limited studies conducted in this region. Therefore, the focus of our study is to understand the prevalence and burden of thalassemia and hemoglobinopathy in Bangladesh. Methods: The analysis was based on a retrospective evaluation of laboratory diagnoses between 2007 January and 2021 October. A total of 8503 specimens were sampled and analyzed which were either referred by corresponding physicians or self-referred. This was neither any epidemiological nationwide survey nor was the study population chosen randomly. Hematological data were obtained through capillary zone electrophoresis and corresponding complete blood count. Results: 1971 samples (~23.18% of the total) were found with at least one inherited hemoglobin disorder. The most common hemoglobin disorder observed was the hemoglobin E (Hb E) trait (10.67%), followed by the β-thalassemia trait (8.4%), homozygotic Hb E (1.59%), and Hb E/β-thalassemia (1.58%). Other variants found in this study with minimal percentages were Hb N-Seattle, Hb S, Hb D-Punjab, Hb Lepore, Hb C, Hb Hope, Hb H, and hereditary persistence of fetal hemoglobin. Discussion: The pattern of thalassemia and hemoglobinopathy in our study is diverse and heterogeneous. A broad and detailed spectrum of such inherited hemoglobin disorders will ultimately be helpful in implementing nationwide thalassemia management and strategy policy in Bangladesh.